Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices

Peptides

Volumn 30, Issue 6, 2009, Pages 1197-1202

  Zhang, Wei ^a   Miao, Jianting ^a   Hao, Jian ^a   Li, Zhen ^a   Xu, Jiang ^a   Liu, Rui ^a   Cao, Fale ^a   Wang, Ruirui ^a   Chen, Jun ^a   Li, Zhuyi ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; HUMANIN; S14G HUMANIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SLICE; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

AMYLOID BETA-PROTEIN; ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HIPPOCAMPUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LONG-TERM POTENTIATION; MALE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS;

EID: 67349199177     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.02.017     Document Type: Article

References (44)

1. Arakawa T., Kita Y., and Niikura T. A rescue factor for Alzheimer's diseases: discovery, activity, structure, and mechanism. Curr Med Chem 15 (2008) 2086-2098
2. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.B., and Teplow D.B. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc Natl Acad Sci USA 100 (2003) 330-335
3. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 3 (1999) 271-276
4. Chen Q.S., Kagan B.L., Hirakura Y., and Xie C.W. Impairment of hippocampal long-term potentiation by Alzheimer amyloid β-peptides. J Neurosci Res 60 (2000) 65-72
5. Chen Q.S., Wei W.Z., Shimahara T., and Xie C.W. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem 77 (2002) 354-371
6. Coleman P.D., and Yao P.J. Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 24 (2003) 1023-1027
7. Freir D.B., Costello D.A., and Herron C.E. A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. J Neurophysiol 89 (2003) 3061-3069
8. Freir D.B., Holscher C., and Herron C.E. Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J Neurophysiol 85 (2001) 708-713
9. Hardy J., and Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12 (1991) 383-388
10. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
11. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., et al. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19 (1999) 8876-8884
12. Hashimoto Y., Ito Y., Niikura T., Shao Z., Hata M., Oyama F., et al. Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein. Biochem Biophys Res Commun 283 (2001) 460-468
13. Hashimoto Y., Niikura T., Tajima H., Yasukawa T., Sudo H., Ito Y., et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci USA 98 (2001) 6336-6341
14. Itoh A., Akaike T., Sokabe M., Nitta A., Iida R., Olariu A., et al. Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats. Eur J Pharmacol 382 (1999) 167-175
15. Jacobsen J.S., Reinhart P., and Pangalos M.N. Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease. NeuroRx 2 (2005) 612-626
16. Kang H., and Schuman E.R. A requirement of local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity. Science 273 (1996) 1042-1046
17. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
18. Krejcova G., Patocka J., and Slaninova J. Effect of humanin analogues on experimentally induced impairment of spatial memory in rats. J Pept Sci 10 (2004) 636-639
19. Kunesová G., Hlavácek J., Patocka J., Evangelou A., Zikos C., Benaki D., et al. The multiple T-maze in vivo testing of the neuroprotective effect of humanin analogues. Peptides 29 (2008) 1982-1987
20. Liu L., Orozco I.J., Planel E., Wen Y., Bretteville A., Krishnamurthy P., et al. A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol Dis 31 (2008) 46-57
21. Lonze B.E., and Ginty D.D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 35 (2002) 605-623
22. Lu Y., Kandel E.R., and Hawkins R.D. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the Hippocampus. J Neurosci 19 (1999) 10250-10261
23. Mamiya T., and Ukai M. [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br J Pharmacol 134 (2001) 1597-1599
24. Miao J., Zhang W., Yin R., Liu R., Su C., Lei G., et al. S14G-humanin ameliorates Abeta25-35-induced behavioral deficits by reducing neuroinflammatory responses and apoptosis in mice. Neuropeptides 42 (2008) 557-567
25. Morgan D. Amyloid, memory and neurogenesis. Exp Neurol 205 (2007) 330-335
26. Oka H., Shimono K., Ogawa R., Sugihara H., and Taketani M. A new planar multielectrode array for extracellular recording: application to hippocampal acute slice. J Neurosci Methods 93 (1999) 61-67
27. Parent A., Linden D.J., Sisodia S.S., and Borchelt D.R. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol Dis 6 (1999) 56-62
28. Patenaude C., Chapman C.A., Bertrand S., Congar P., and Lacaille J.C. GABAB receptor- and metabotropic glutamate receptor-dependent cooperative long-term potentiation of rat hippocampal GABAA synaptic transmission. J Physiol 553 (2003) 155-167
29. Puzzo D., Vitolo O., Trinchese F., Jacob J.P., Palmeri A., and Arancio O. Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. J Neurosci 25 (2005) 6887-6897
30. Rowan M.J., Klyubin I., Wang Q., Hu N.W., and Anwyl R. Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction. Biochem Soc Trans 35 (2007) 1219-1223
31. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
32. Small D.H., Mok S.S., and Bornstein J.C. Alzheimer's disease and Abeta toxicity: from top to bottom. Nat Rev Neurosci 2 (2001) 595-598
33. Tajima H., Kawasumi M., Chiba T., Yamada M., Yamashita K., Nawa M., et al. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice. J Neurosci Res 79 (2005) 714-723
34. Tchantchou F., Xu Y., Wu Y., Christen Y., and Luo Y. EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease. FASEB J 21 (2007) 2400-2408
35. Tong L., Thornton P.L., Balazs R., and Cotman C.W. Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised. J Biol Chem 276 (2001) 17301-17306
36. Trinchese F., Liu S., Battaglia F., Walter S., Mathews P.M., and Arancio O. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Ann Neurol 55 (2004) 801-814
37. Vitolo O., Gong B., Cao Z., Ishii H., Jaracz S., Nakanishi K., et al. Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide. J Neurobiol Aging 30 (2009) 257-265
38. Vitolo O.V., Sant'Angelo A., Costanzo V., Battaglia F., Arancio O., and Shelanski M. Amyloid peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signalling. Proc Natl Acad Sci USA 99 (2002) 13217-13221
39. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
40. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 (2004) 181-193
41. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., et al. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924 (2002) 133-140
42. Wang Q., Walsh D.M., Rowan M.J., Selkoe D.J., and Anwyl R. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J Neurosci 24 (2004) 3370-3378
43. Xu X., Chua C.C., Gao J., Hamdy R.C., and Chua B.H. Humanin is a novel neuroprotective agent against stroke. Stroke 37 (2006) 2613-2619
44. Xu Y., Cui C., Pang C., Christen Y., and Luo Y. Restoration of impaired phosphorylation of cyclic AMP response element-binding protein (CREB) by EGb 761 and its constituents in Abeta-expressing neuroblastoma cells. Eur J Neurosci 26 (2007) 2931-2939